France is set to become the first European Union country to reimburse anti-obesity medications for severely obese patients starting mid-June. The government estimates this initiative will cost approximately €100 million annually. This policy aims to cover drugs like Novo Nordisk's Wegovy and Eli Lilly's Mounjaro, which have seen a surge in interest globally. AI
RANK_REASON First-in-EU policy change regarding reimbursement for a new class of drugs. [lever_c_demoted from significant: ic=1 ai=0.0]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
